Literature DB >> 9871543

Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases.

M Legraverend1, O Ludwig, E Bisagni, S Leclerc, L Meijer.   

Abstract

The synthesis of a new family of inhibitors of the cell cycle regulating cyclin-dependent kinases (CDK's) is reported. These compounds, related to the purines olomoucine and roscovitine, are characterised by the presence of alkynylated side chains at C2. They inhibit CDK's with IC50's in the 200 nM range.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871543     DOI: 10.1016/s0960-894x(98)00097-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Structure-based design of potent CDK1 inhibitors derived from olomoucine.

Authors:  P Furet; J Zimmermann; H G Capraro; T Meyer; P Imbach
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.